Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARSS: Albumin 20% vs Saline in Septic Shock
NCT00327704Phase 4Completed
- Sponsor
- LFB Group
- Start
- Jul 2006
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in septic shock, sponsored by LFB Group. Started Jul 2006; status: completed.
02
Drugs
albumin (human)
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00327704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327704.